Clinical Trials
9 trialsNCT01445509 2026-05-22
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT04733534 2026-04-24
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT01636908 2021-04-15
ICK
Amsterdam UMC, location VUmc
Phase NA Completed
NCT01999985 2020-11-27
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00820170 2019-08-13
Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT02015728 2016-12-15
SEED
Seattle Children's Hospital
Phase NA Unknown
NCT00099606 2011-04-19
Phase I (PH I) Mad Refractory Solid Tumor Study
Bristol-Myers Squibb
Phase 1 Completed
NCT00162214 2011-04-14
Study of Dasatinib in Patients With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Terminated
NCT00339144 2010-12-15
Study of Dasatinib (BMS-354825) in Patients With Solid Tumors
Bristol-Myers Squibb
Phase 1 Completed